193 related articles for article (PubMed ID: 11369890)
1. Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-induced immortalization and virus activation.
Konishi K; Maruo S; Kato H; Takada K
J Gen Virol; 2001 Jun; 82(Pt 6):1451-1456. PubMed ID: 11369890
[TBL] [Abstract][Full Text] [Related]
2. Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection.
Rechsteiner MP; Berger C; Zauner L; Sigrist JA; Weber M; Longnecker R; Bernasconi M; Nadal D
J Virol; 2008 Feb; 82(4):1739-47. PubMed ID: 18057232
[TBL] [Abstract][Full Text] [Related]
3. Tyrosines 60, 64, and 101 of Epstein-Barr virus LMP2A are not essential for blocking B cell signal transduction.
Swart R; Fruehling S; Longnecker R
Virology; 1999 Oct; 263(2):485-95. PubMed ID: 10544120
[TBL] [Abstract][Full Text] [Related]
4. Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction.
Fruehling S; Lee SK; Herrold R; Frech B; Laux G; Kremmer E; Grässer FA; Longnecker R
J Virol; 1996 Sep; 70(9):6216-26. PubMed ID: 8709248
[TBL] [Abstract][Full Text] [Related]
5. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking.
Miller CL; Lee JH; Kieff E; Longnecker R
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):772-6. PubMed ID: 8290598
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice.
Vrazo AC; Chauchard M; Raab-Traub N; Longnecker R
PLoS Pathog; 2012; 8(4):e1002662. PubMed ID: 22536156
[TBL] [Abstract][Full Text] [Related]
7. The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential.
Longnecker R; Miller CL; Miao XQ; Marchini A; Kieff E
J Virol; 1992 Nov; 66(11):6461-9. PubMed ID: 1328675
[TBL] [Abstract][Full Text] [Related]
8. The LMP2A signalosome--a therapeutic target for Epstein-Barr virus latency and associated disease.
Portis T; Cooper L; Dennis P; Longnecker R
Front Biosci; 2002 Feb; 7():d414-26. PubMed ID: 11815296
[TBL] [Abstract][Full Text] [Related]
9. Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells.
Rechsteiner MP; Berger C; Weber M; Sigrist JA; Nadal D; Bernasconi M
J Gen Virol; 2007 May; 88(Pt 5):1454-1459. PubMed ID: 17412973
[TBL] [Abstract][Full Text] [Related]
10. Role of latent membrane protein 2 isoforms in Epstein-Barr virus latency.
Rechsteiner MP; Bernasconi M; Berger C; Nadal D
Trends Microbiol; 2008 Nov; 16(11):520-7. PubMed ID: 18835714
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.
Swanson-Mungerson MA; Caldwell RG; Bultema R; Longnecker R
J Virol; 2005 Jun; 79(12):7355-62. PubMed ID: 15919890
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus LMP2A imposes sensitivity to apoptosis.
Swanson-Mungerson M; Bultema R; Longnecker R
J Gen Virol; 2010 Sep; 91(Pt 9):2197-202. PubMed ID: 20484564
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency.
Fruehling S; Swart R; Dolwick KM; Kremmer E; Longnecker R
J Virol; 1998 Oct; 72(10):7796-806. PubMed ID: 9733815
[TBL] [Abstract][Full Text] [Related]
14. K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.
Steinbrück L; Gustems M; Medele S; Schulz TF; Lutter D; Hammerschmidt W
J Virol; 2015 Jul; 89(14):7248-61. PubMed ID: 25948739
[TBL] [Abstract][Full Text] [Related]
15. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS
J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes.
Miller CL; Longnecker R; Kieff E
J Virol; 1993 Jun; 67(6):3087-94. PubMed ID: 7684459
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation.
Incrocci R; Hussain S; Stone A; Bieging K; Alt LA; Fay MJ; Swanson-Mungerson M
Cell Immunol; 2015 Oct; 297(2):108-19. PubMed ID: 26255694
[TBL] [Abstract][Full Text] [Related]
18. PY motifs of Epstein-Barr virus LMP2A regulate protein stability and phosphorylation of LMP2A-associated proteins.
Ikeda M; Ikeda A; Longnecker R
J Virol; 2001 Jun; 75(12):5711-8. PubMed ID: 11356981
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of host kinase activity altered by the LMP2A signalosome-a therapeutic target for Epstein-Barr virus latency and associated disease.
Cooper L; Longnecker R
Antiviral Res; 2002 Dec; 56(3):219-31. PubMed ID: 12406506
[TBL] [Abstract][Full Text] [Related]
20. Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential.
Ma SD; Tsai MH; Romero-Masters JC; Ranheim EA; Huebner SM; Bristol JA; Delecluse HJ; Kenney SC
J Virol; 2017 Apr; 91(7):. PubMed ID: 28077657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
